immusoft to present data highlighting positive results from the worlds first engineered b cell in a human clinical trial at asgct 2026

TAX_DISEASE_RARE_DISEASESWB_678_DIGITAL_GOVERNMENTWB_694_BROADCAST_AND_MEDIAWB_133_INFORMATION_AND_COMMUNICATION_TECHNOLOGIES

The full article is on the original publisher site. This page only shows the headline and a very short excerpt.